Invivyd (IVVD) Presents at the 43rd Annual Cowen Healthcare Conference - Slideshow

FORWARD LOOKING STATEMENTS All trademarks in this presentation are the property of their respective owners. 2 2 INVIVYD No vaccine alternatives for prevention • 116 million adults in U.S. with comorbidities7 VYD222 is an investigational product candidate not approved for use in any country. The safety and efficacy of VYD222 have not been established. VYD INVIVYD Continuous monitoring of viral evolution coupled with rapid antibody discovery and engineering to address the evolving SARS-CoV-2 threat Monitor va ...